|
Originally published In Press as doi:10.1074/jbc.M203539200 on May 9, 2002
J. Biol. Chem., Vol. 277, Issue 29, 25970-25975, July 19, 2002
Thioredoxin Reductase Is Essential for the Survival of
Plasmodium falciparum Erythrocytic Stages*
Zita
Krnajski §,
Tim-Wolf
Gilberger ¶ ,
Rolf D.
Walter ,
Alan F.
Cowman , and
Sylke
Müller **
From the Bernhard Nocht Institute for Tropical
Medicine, Department of Biochemical Parasitology,
20359 Hamburg, Germany, ¶ The Walter and Eliza Hall Institute of
Medical Research, P. O. Royal Melbourne Hospital,
3050 Melbourne, Victoria, Australia, and ** University of
Dundee, School of Life Sciences,
Dundee DD1 5EH, Scotland, United Kingdom
Received for publication, April 12, 2002, and in revised form, May 3, 2002
 |
ABSTRACT |
The human malaria parasite
Plasmodium falciparum poses an increasing
threat to human health in the tropical regions of the world, and the
validation and assessment of possible drug targets is required for the
development of new antimalarials. It has been shown that the
erythrocytic stages of the parasites, which are responsible for the
pathology of the disease in humans, are under enhanced oxidative stress
and are particularly vulnerable to exogenous challenges by reactive
oxygen species. Therefore it is postulated that the disruption of the
antioxidant and/or redox systems of the parasite is a feasible way to
interfere with their development during erythrocytic schizogony. In
order to test this suggestion thioredoxin reductase (TrxR), an enzyme
heavily involved in maintenance of redox homeostasis and antioxidant
defense, was knocked out in P. falciparum. It was
impossible to generate parasites with a disrupted trxR gene
suggesting that TrxR is essential for P. falciparum
erythrocytic stages. Technical problems were excluded by transfecting a
3' replacement construct, which recombined correctly and transfectants
did not show any phenotypic alterations. In order to prove that the
trxR knockout was responsible for the lethal phenotype of
the null mutants, a co-transfection with both the knockout construct
and a construct containing the trxR coding region under the
control of the calmodulin promoter was conducted. Despite the
disruption of the trxR gene, parasites were viable. In a
Southern blot analysis a complicated restriction pattern was obtained,
but it was shown by pulse field gel electrophoresis and field inverse
gel electrophoreses that only the trxR gene locus on
chromosome 9 was targeted by the constructs. It was found that
the co-transfected constructs form concatemeric structures prior to
integration into the trxR gene locus, which is further supported by plasmid rescue followed by restriction analyses of the
plasmids. Northern and Western blot analyses proved that the co-transfectants highly overexpress TrxR from the introduced gene. Our
results demonstrate that TrxR is essential for the survival of the
erythrocytic stages of P. falciparum.
 |
INTRODUCTION |
Aerobic organisms are exposed to reactive oxygen species
(ROS),1 which are generated
as by-products of their metabolism throughout their lives. ROS are
combated by the organism with antioxidative systems, which include
enzymes such as superoxide dismutase, catalase, and peroxidases as well
as non-enzymatic antioxidants like glutathione and vitamins E and C
(1). These antioxidants prevent damage of nucleic acids, proteins, and
membrane integrity and are crucial for the survival in an aerobic
environment (1, 2). Parasites have not only to cope with the oxidative
stress generated by their own metabolic reactions but also have to
fight ROS generated by the host immune system.
Plasmodium falciparum, the causative agent of
malaria tropica, is one of the major threats to human health in the
tropical regions of the world. The parasites have developed resistance to most commonly used drugs, and it is of great interest to identify, validate, and assess new potential targets suitable for the design of
novel chemotherapeutics. The fact that Plasmodium-infected erythrocytes are under enhanced oxidative stress together with their
susceptibility to exogenous oxidative challenge is a reason to believe
that the antioxidant systems of the parasite are important for the
survival of the parasite during their erythrocytic life stages
(3-5).
It was shown that P. falciparum possesses two functional
redox systems, which involve the low molecular weight thiol glutathione and the 12-kDa protein thioredoxin (Trx) (6-11). Both are part of
enzymatic redox cascades, which transfer electrons from NADPH to
acceptor molecules such as hydrogen peroxide and alkyl hydroperoxides but also proteins like ribonucleotide reductase and a number of transcription factors (12-19). Thus these systems are heavily involved in the redox regulation of the cell and are thought to contribute greatly to the antioxidant capacity of the cell.
Thioredoxin reductase (TrxR) is a flavo oxidoreductase, which exists in
two different types in nature. The low molecular weight type occurs in
bacteria, plants, and fungi, whereas mammalian cells, the fruit fly
Drosophila melanogaster, the nematode
Caenorhabditis elegans, and the malaria
parasite P. falciparum contain the high molecular weight
type of reductase (20-28). Plasmodium TrxR has been
investigated intensively and by employing mutagenesis and kinetic
studies showed that it differs significantly from its mammalian
counterpart (10, 21, 29, 30). Both proteins belong to the family of
high molecular weight TrxR, but due to different active site residues
they are distinct in their substrate and inhibitor profiles that may be
exploitable for the design of antimalarials (21). To establish the
significance of the protein for the survival of P. falciparum, we have genetically modified blood stage forms of
parasites and have demonstrated that TrxR is indeed essential for their survival.
 |
EXPERIMENTAL PROCEDURES |
Materials--
[ -32P]ATP (3000 Ci/mmol) and the
ECL Western blot detection system were purchased from Amersham
Biosciences. Albumax II and RPMI 1640 were from Invitrogen.
Pyrimethamine was purchased from Sigma. WR 99120 was a kind gift of Dr.
Jacobus, Jacobus Pharmaceuticals.
Generation of TrxR Transfection Constructs--
The TrxR
knockout construct was generated by PCR using Pfu polymerase
with P. falciparum 3D7 genomic DNA as a template and the specific oligonucleotides
5'-GGAAGATCTGTTTTATTGTTTGATTATGTAAAGCC-3' and
5'-CCGCTCGAGTTATCCACATGCACCATATTCAATAGG-3' to obtain a
1028-bp fragment. The fragment starts at position 196 of the trxR open reading frame and ends at position 1224 where an
artificial stop codon was introduced into the oligonucleotide (Fig.
1A). The sense oligonucleotide
contains a BglII restriction site (boldface), and the
antisense oligonucleotide contains an XhoI restriction site
(boldface) in order to allow directional cloning into the previously
cut transfection plasmid pHH1 (31) (see Fig. 1A) resulting
in construct pHH1TrxR-ko. The 3' replacement control fragment was
amplified from genomic DNA with the oligonucleotides 5'-GCGCGAGATCTCATATACCAGATGATGTTGAAGG-3' and
5'-GCGCGCTCGAGTTATCCACATTTTCCACCCCCAC-3' also
containing the restriction sites required for cloning into pHH1. The
fragment represents 1037 bp, starts at position 589 of the coding
region of trxR and includes the genuine stop-codon at its
3'-end. The resulting construct is called pHH1TrxR-3'R (Fig.
1B).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic presentation of the constructs used
for transfection. The transfection plasmids pHH1TrxR-ko
(A), pHH1TrxR-3'R (B), and pHC1TrxR-Ex
(C) and their arrangement after a homologous recombination
event into the trxR gene locus are shown. BglII,
DraIII, NotI, and XhoI restriction
sites are indicated. A, pHH1TrxR-ko contains a 1024-bp
fragment of trxR starting 196 bp downstream of the ATG
initiation codon and carries an artificially introduced stop codon at
its 3'-end. The knockout fragment possesses the 3' region of P. berghei dihydrofolate reductase thymidylate synthase. After
homologous recombination, the endogenous 5-kb
NotI/DraIII fragment should disappear upon
Southern blot analysis, and new bands at 1.85 and 9.95 kb should appear
when using the trxR-ko region as a probe. B,
pHH1TrxR-3'R encompasses a 1037-bp fragment of the 3' region of
trxR starting at position 1224 of trxR and
possesses the genuine stop codon at its 3'-end. Upon homologous
recombination into the trxR locus, the endogenous 5-kb
restriction fragment obtained with NotI and
DraIII should disappear, and new bands at 2.29 and 9.5 kb
should appear. The pHH1 plasmids were initially constructed on a
pGEM-3Z (Promega) vector backbone and contain the human DHFR as
selection marker under control of the P. falciparum
calmodulin promoter and the histidine-rich protein 2 (HRP2)
3' region. C, the TrxR overexpression plasmid carries the
entire coding region of trxR under control of the calmodulin
promoter and the heat shock protein 86 (HSP86) 3' region.
pHC1 also has the pGEM-3Z vector backbone but contains the
Toxoplasma gondii DHFR-TS as selection marker under control
of the Plasmodium chabaudi DHFR-TS promoter and
histidine-rich protein 2 3' region. Arrows indicate the
location of primers used in the PCR analysis of D10TrxR-ko and
D10TrxR-3'R parasites shown in Fig. 5. The abbreviations used are as
follows: DHFR-TS, dihydrofolate reductase thymidylate
synthase; trxR, thioredoxin reductase; trxR-ko,
thioredoxin reductase knockout fragment; trxR-3',
thioredoxin reductase 3'-end; HSP6-3', P. falciparum heat shock protein 86 3'-UTR.
|
|
In order to be able to clone the txrR coding region into the
overexpression plasmid pHC1, an XhoI site was mutated
according to Gilberger et al. (10) using the
oligonucleotides sense 5'- GCTGCAGCACATGGTGCCCGGGTTTTATTGTTTGATTATG-3', antisense
5'-CATAATCAAACAATAAAACCCGGGCACCATGTGCTGCAGC-3', Pfu
polymerase, and the expression plasmid pJC40-TrxR (10) as a template in
a PCR-based protocol. The PCR fragment was cloned into the TOPO T/A
vector (Invitrogen), and the mutation was verified by nucleotide
sequencing. Subsequently, trxR was amplified from the TOPO
clone with the specific oligonucleotides sense
5'-GCGCGCTCGAGAAAAACATGTGTAAAGATAAAAACG-3' and antisense
5'-GCGCGCTCGAGTTATCCACATTTTCCACCCCCAC-3'. Both
oligonucleotides possess an XhoI site (boldface) to allow subcloning of the PCR fragment into the P. falciparum
overexpression plasmid pHC1 (32) resulting in plasmid pHC1TrxR-Ex (Fig.
1C). The nucleotide sequences of all constructs were
verified by automated sequencing on an ABI 377 (Applied Biosystems
Inc.). Plasmid DNA was prepared using the Qiagen Maxi Prep kit (Qiagen).
Parasites and Transfection of Erythrocytic Stages--
P.
falciparum D10 was cultivated according to Trager and Jensen (33)
in RPMI 1640 medium containing 5% human serum O+ and
0.05% Albumax II in human erythrocytes blood group O+
under a reduced oxygen atmosphere. Prior to transfection parasites were
synchronized by sorbitol lysis (34). Transfection was carried out as
described previously (35-37) with 100 µg of circular DNA of either
pHH1TrxR-ko, pHH1TrxR-3'R, or both pHH1TrxR-ko and pHC1TrxR-Ex. Transfected parasites were cultured in 90-mm Petri dishes for 48 h
without drug pressure before the medium was supplemented with 0.2 µM pyrimethamine for 2 days followed by selection with 0.1 µM pyrimethamine until 5% parasitemia was reached.
The first parasites were observed after 21-32 days of selection. In
order to select for homologous recombination of the constructs and loss of episomal DNA, transfectants were cultivated for 3 weeks without drug
pressure followed by 2 weeks with pyrimethamine pressure. This
selection cycle was repeated for several rounds, and at different stages parasite DNA was isolated and subjected to Southern blotting and
PCR analyses to determine whether episomal DNA was present and whether
integration into the trxR gene locus had occurred. After 3 rounds of selection, parasites were cloned by limiting dilution (38)
and used for genotypic and phenotypic analyses. In the case of the
co-transfection of knockout and overexpression constructs, clones were
generated using selection with pyrimethamine (0.1 µM) and
WR 99120 (5 nM).
Analyses of Genotypes--
PCR analyses of transfectants were
performed with AccuPrimeTM Taq polymerase
(Invitrogen) using genomic DNA of parasites as template. PCR was
performed with trxR sense oligonucleotides
5'-ATAGCAACAGGATGTAGACC-3' or 5'-ATAGGAGGAGGTCCAGCTGG-3', respectively
and the pHH1-specific antisense oligonucleotide
5'-CAGTTATAAATACAATCAATTGG-3'. The PCR conditions are as follows:
1 cycle of 95 °C (3 min) and 35 cycles of 95 (1 min), 46 (1 min),
and 60 °C (1.5 min).
DNA and RNA were isolated from wild type parasites and transfectants as
described elsewhere (39, 40). 15 µg of genomic DNA were digested with
NotI and DraIII, separated on a 0.8% agarose gel, and transferred to positively charged nylon membranes (Roche Molecular Biochemicals). Subsequently the membranes were hybridized with either the trxR knockout fragment or the 3'-UTR of
PbDT specific for pHH1TrxR-ko in order to identify the
genotype of the respective parasite clone. Northern blots were
performed according to Kyes et al. (40) and probed with the
coding region of trxR.
In order to analyze the genotype of co-transfected parasite clones in
addition to Southern blot analyses, a pulse field gel electrophoresis
(PFGE) was performed. The chromosomes were separated by using contour
clamped homogenous field apparatus at 4.2 V cm 1 and a
pulse time of 225 s for 72 h (41). The blots were hybridized with three different probes (trxR knockout fragment, pGEM
vector backbone, and PbDT-3' region).
Furthermore, a field inverse gel electrophoreses (FIGE) was carried
out. Genomic DNA of co-transfectants was digested with ClaI,
a restriction enzyme that cuts rarely in the P. falciparum genome, and the fragments were separated on a 1% agarose gel in a FIGE
(at 200 V and a pulse time of 0.8-1.5 s for 16 h). The DNA was
blotted onto positively charged nylon membrane and hybridized with the
trxR-coding region and PbDT-3' region according
to standard methods (42).
Plasmid Rescue from Co-transfected Parasites--
DNA from
co-transfected parasites was isolated as described above and
subsequently used to transform Escherichia coli DH5 . Bacterial clones were grown overnight in Luria-Bertani medium containing 50 µg/ml ampicillin and plasmid DNA was isolated according to Sambrook et al. (42). DNA was restricted with
BglII and XhoI in single digests and double
digests and subsequently separated on a 1% agarose gel.
Western Blot Analysis--
Proteins of wild type and transfected
parasite clones were isolated after saponin lysis (43). For Western
blot analyses 5-µl aliquots of parasite pellets were resuspended in
10 µl of 2× SDS sample buffer containing 5% 2-mercaptoethanol,
separated on a 7.5% SDS-PAGE, and subsequently blotted onto
nitrocellulose according to Sambrook et al. (42). The blots
were blocked in 3% bovine serum albumin for 1 h and subsequently
incubated with the primary rabbit anti-TrxR antiserum (1:1000) for
1 h at room temperature. As a loading control the blots were
probed with antibodies raised against 1-Cys peroxiredoxin of
P. falciparum (1:2000) (14). Afterward the blots were washed
twice in Tris-buffered saline containing 0.1% Tween 20 (TBS-Tween),
and the secondary anti-rabbit horseradish peroxidase-conjugated
antibody was applied (1:10,000) for 1 h before the blot was washed
in TBS-Tween and developed using the ECL detection system and exposed
to BioMax MR-1 films (Eastman Kodak).
 |
RESULTS |
Transfection of P. falciparum--
In order to elucidate the
significance of TrxR in P. falciparum, it was attempted to
generate trxR null mutants transfecting them with
pHH1TrxR-ko (Fig. 1A). However, it proved difficult to
obtain viable parasites, and there are a number of possible explanations as follows: (i) problems with the transfection technique, (ii) occurrence of an antisense effect (44, 45), or (iii) trxR knockout has a lethal effect.
In order to exclude that the failure to obtain stable trxR
null mutants is due to technical problems, a control construct was
transfected that replaces the 3' region of the gene upon homologous recombination without disrupting it (see Fig. 1B) (46). By
using this construct, parasites grew normally, and it was shown by
Southern blot analyses that recombination events into the
trxR locus already started to occur during the 1st cycle of
pyrimethamine selection (Fig. 2). The
transfectants were cloned, and Southern blot analyses were performed.
Fig. 2 shows that clone 3 contains pHH1TrxR-3'R integrated in the
trxR locus. Importantly, the transfectants did not show any
phenotypic changes, and their growth was comparable with wild type
P. falciparum D10. These results demonstrate that the
trxR gene locus is targeted by the constructs transfected and supports the suggestion that the difficulty in obtaining
trxR null mutants was due to the disruption of the
trxR gene.

View larger version (84K):
[in this window]
[in a new window]
|
Fig. 2.
Southern blot analysis of D10TrxR-3'R
parasites. Genomic DNA was digested with
NotI/DraIII. Lane 1, after
transfectants grow up, they contain an episomal copy (6.8 kb) of
pHH1TrxR-3'R and the 5-kb endogenous trxR fragment.
Lane 2, in the 1st cycle a correct integration of
pHH1TrxR-3'R into the trxR locus has occurred (appearance of
two new fragments of 2.29 and 9.5 kb, respectively); the parasites
still contain episomes (6.8 kb) and the endogenous gene (5 kb).
Lanes 3 and 4, D10TrxR-3'R clones; clone 1 (lane 3) still contains episomes in addition to the
integrated plasmid. Clone 3 (lane 4) has integrated
pHH1TrxR-3'R correctly into the trxR gene locus as only the
new bands (2.29 and 9.5 kb) appear, and the clone has lost all episomal
copies of pHH1TrxR-3'R. M, 1-kb ladder (MBI Fermentas). The
blot was probed with trxR-ko fragment.
|
|
To confirm that we could target the trxR gene and disrupt
its expression, we made transfection constructs that would disrupt the
gene and complement lack of expression with an introduced trxR transgene (46). Parasites were concomitantly
transfected with the knockout construct pHH1TrxR-ko and the
overexpression construct pHC1TrxR-Ex (Fig. 1C), and the
transfectants survived several selection cycles. In order to verify
that the parasites contained both constructs, a plasmid rescue
experiment was performed. 10 independent bacterial clones were
analyzed. Interestingly, the restriction pattern obtained show that the
knockout and overexpression plasmids have recombined after
transfection. Furthermore, only two different variants of clones could
be isolated, implicating that "hot spots" exist where the plasmids
prefer to recombine (Fig. 3) (47,
48).

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 3.
Plasmid rescue of co-transfectants.
Re-isolated episomes from co-transfected P. falciparum
parasites were digested with XhoI, BglII, and
XhoI/BglI. The pattern of the double digest of
clones 1 and 2 shows that both plasmids (pHH1TrxR-ko and pHC1TrxR-Ex)
are present and have formed two different megaplasmids (chimera of both
plasmids). In clone 1 the appearance of a 1- and a 5.8-kb band upon
double digest shows that the pHH1TrxR-ko plasmid is present and that
the 1-kb trxR knockout fragment is cut out with
XhoI/BglII. The additional three bands (4.8, 2.4, and 1.6 kb) are attributable to pHC1TrxR-Ex where the trxR
full-length gene is cut out with XhoI (see Fig. 1,
A and C, for location of XhoI and
BglII restriction sites). Clone 2 shows a different
restriction pattern, which is due to different recombination events of
pHH1TrxR-ko and pHC1TrxR-Ex compared with clone 1. Nevertheless, the
1-kb trxR knockout fragment and the 1.6-kb trxR
full-length overexpression fragment are present. M, 1-kb
ladder (MBI Fermentas).
|
|
These parasites were cloned to determine the nature of the plasmids
co-transfected. The clones 7D and 11E were chosen for further analyses
because they were shown to carry both plasmid constructs in some form.
To prove the assumption that the clones no longer possess episomal DNA
but have integrated the recombined plasmids into the trxR
locus, they were analyzed by PCR, Southern blotting, PFGE, and
FIGE.
Southern blot analyses of both clones showed a complicated
hybridization pattern when probed with the trxR-ko fragment
as shown in Fig. 4A. The new
band at 1.85 kb, however, strongly indicates that the endogenous
trxR gene has been disrupted by pHH1TrxR-ko (see Fig.
1A). Disruption of the endogenous trxR by
pHH1TrxR-ko was verified by PCR analysis using primers that
specifically bind upstream of the trxR knockout fragment and
within the PbDT-3' region of pHH1TrxR-ko knockout construct
(Fig. 5). In addition numerous other
bands are found in the Southern blot, and we analyzed this genotype
further by probing it with PbDT-3'. The 1.85-kb band
diagnostic for the disruption of the endogenous trxR gene was also obtained with this probe, and a second band at 3.2 kb appears
on the blot, indicating that at least two copies of pHH1TrxR-ko are
present in the transfectants. The fact that DraIII only cuts pHC1TrxR-Ex once and NotI only cuts pHH1TrxR-ko once and
there are no endogenous DraIII or NotI sites near
the trxR gene locus, the appearance of several bands in the
Southern blot indicates that they originate from recombined episomes
and not from recombination events into other gene loci of the
Plasmodium genome.

View larger version (90K):
[in this window]
[in a new window]
|
Fig. 4.
Southern blot analyses of co-transfected
parasite clones Co-7D and Co-11E hybridized with four different probes:
trxR-ko fragment (A) and
PbDT-3'-UTR (B). Genomic DNA was
digested with NotI (N), DraI
(D), and NotI/DraI (N/D).
In both clones the appearance of the 1.85-kb
NotI/DraIII fragments (arrows), which
hybridize with trxR and PbDT-3'-UTR-specific
probes, indicates that the endogenous trxR-ko has been
disrupted by pHH1TrxR-ko. The other bands are attributable to the
formation of a megaplasmid (chimera), which contains both pHH1TrxR-ko
and pHC1TrxR-Ex. For the exact location of the probes see Fig. 1,
A and C. The abbreviations used are as follows:
Co-7D and Co-11E, parasite clones 7D and 11E that
were co-transfected with both plasmids, pHH1TrxR-ko containing the
knockout fragment of trxR and pHC1TrxR-Ex overexpressing
trxR; trxR, thioredoxin reductase.
|
|

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 5.
PCR analyses of co-transfectants. Clones
Co-7D and Co-11E were used as template for the PCR-based analysis of
the disruption of the endogenous trxR gene. Co-7D
and Co-11E, sense primer binds upstream of the TrxR knockout
fragment; the antisense primer is specific for pHH1 (see
arrows in Fig. 1A for exact location of primers).
+, positive control PCR using primers specific for
pHH1TrxR-ko; , negative control without DNA.
|
|
This interpretation was confirmed by PFGE, using chromosomes from wild
type Plasmodium and the transfectants (Fig.
6). Hybridization of the blot with the
trxR-ko fragment resulted in a single signal on chromosome
9. In clones 7D and 11E the bands have shifted slightly and also the
intensities of the signal appear to be higher. The shift in size
of the chromosome may be attributable to the integration of a
concatamer of pHH1TrxR-ko and pHC1TrxR-Ex which leads to quite a
considerable increase of size but also may have structural implications
on the chromosome. It has been suggested by O'Donnel et al.
(48) that the formation of concatamers (namely trimers) during
replication of the parasites is essential for correct segregation and
maintenance of the episomes during schizogony, and therefore our
results are not surprising. The formation of such concatameric structures was established by a FIGE with subsequent blotting. As shown
in Fig. 7, after ClaI
restriction of P. falciparum D10 genomic DNA, a band of 30 kb was detectable using the trxR probe. This band shifts by
at least 20 kb to a size ranging between 50 and 90 kb in clone 11E
indicating that several copies of the transfection constructs were
integrated into the trxR locus. Another important finding of
this experiment is that the pHH1TrxR-ko-specific probe PbDT-3' also hybridized to the same band, further supporting
our suggestion that the endogenous txrR gene of these clones
is disrupted. Presumably, the survival of the parasites is ensured by
overexpression of TrxR from the co-transfected plasmid. These findings
strongly suggest that TrxR is essential for the survival of P. falciparum during the erythrocytic development and validate this
protein as a target for chemotherapy of malaria.

View larger version (99K):
[in this window]
[in a new window]
|
Fig. 6.
Pulse field gel electrophoresis of
co-transfected parasite clones 7D (Co-7D) and 11E (Co-11E) in
comparison with D10. The blot was hybridized with three different
probes: trxR-ko, pGEM vector backbone, and
PbDT-3'. All three probes hybridize to the same chromosome
in the co-transfected clones 7D and 11E, which indicates that
integration of the megaplasmid has occurred into chromosome 9. The
hybridization of PbDT-3', which is specific for pHH1TrxR-ko,
with chromosome 9 proves that the knockout construct is present in the
chromosome, and therefore homologous recombination must have occurred.
To assign the chromosomes, the Yeast Chromosome PFG Marker and
the data from Thompson et al. (53) were used. The
abbreviations used are as follows: chr., chromosome;
trxR, thioredoxin reductase; pGEM, pGEM vector
backbone.
|
|

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 7.
FIGE of co-transfected parasite clone 11E
(Co-11E) in comparison with D10. DNA was digested
with ClaI and separated by FIGE. The blot was hybridized
with two different probes (trxR-ko fragment and
PbDT-3'). The hybridizing fragment of Co-11E is at least 20 kb larger than the fragment of D10. This demonstrates that at least
three copies of plasmids are integrated with one of them being the
knockout construct as the probe PbDT-3', which is specific
for pHH1TrxR-ko, hybridizes with this fragment. Sizes were estimated
using Yeast Chromosome PFG Marker and Lambda DNA-HindIII
Digest Standards (New England Biolabs). The abbreviations used are as
follows: trxR, thioredoxin reductase; pGEM, pGEM
vector backbone.
|
|
Northern and Western Blot Analyses--
Total RNA of wild type D10
and the transfectants (TrxR-3'R, Co-7D, and Co-11E) was separated on a
1.5% agarose gel containing 5 mM guanidine thiocyanate,
transferred to nylon membranes, and subsequently hybridized with a
trxR probe. Fig. 8 shows that
the message of trxR (3.2 kb) in wild type and control clone
TrxR-3'R is present in equal amounts, whereas in clones 11E and 7D the message was greatly increased. These results are consistent with the
fact that several copies of pHC1TrxR-Ex are present in both clones and
that transcription of the recombinant gene is driven by the strong
calmodulin promoter (32).

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 8.
Northern blot analysis of transfectants.
Northern blot analysis of co-transfectants 7D (Co-7D) and
11E (Co-11E) in comparison with wild type D10 and
trxR-3' parasites. The expression levels are increased
severalfold in co-transfectants, which proves that the construct
pHC1TrxR-Ex leads to overexpression of trxR mRNA in the
co-transfected parasites and complements the lethal trxR
knockout. rRNA was used as a loading control. The size of the mRNA
was estimated using RNA Markers 0.28-6.58 (Promega).
TrxR-3', thioredoxin reductase 3'-replacement parasite clone
3.
|
|
To determine whether the level of expression of TrxR was also increased
in the Co-7D and Co-11E parasites, we used Western blot analyses of
parasite lysates. These were separated on SDS-PAGE, blotted onto a
nitrocellulose membrane, and incubated with antibodies raised against
TrxR. Consistent with the elevated TrxR mRNA observed in the
Northern blot analyses, the wild type and the TrxR-3'R clone clearly
show a weak band at 60 kDa, whereas a strong overexpression was found
in clones 7D and 11E (Fig. 9). As a
loading control antibodies raised against the 1-Cys peroxiredoxin from
P. falciparum were used (14). Our results demonstrate that
the integration of pHH1TrxR-3'R into the trxR gene locus has
no deleterious effect on the expression of the protein. This result was
not surprising, because we had already shown that the transfectants do
not show any detectable phenotypic differences. Furthermore, using
1-Cys peroxiredoxin as a loading control in the Western blot
experiment implies that the expression of proteins involved in the
antioxidative defense mechanism and possibly interacting directly with
the Trx system was not affected either. Most importantly the results
presented here show that co-transfection of knockout and overexpression constructs is a possibility to complement loss of function of a lethal
knockout in P. falciparum.

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 9.
Western blot analysis. The Western blot
analysis shows the higher expression of TrxR (60 kDa) in the
co-transfectants (Co7D and Co11E) in comparison
with D10 and TrxR-3'R parasites. The loading control represents
1-Cys peroxiredoxin (24 kDa) from P. falciparum and
shows that similar amounts of protein were loaded in the different
lanes of the gel. Furthermore, it shows that no alterations in the
expression of this protein upon transfection of the parasites occur. To
estimate the size of the protein, Kaleidoskop Prestained Standards
(Bio-Rad) were used. Px1, antibodies raised against
1-Cys peroxiredoxin; TrxR, antibodies raised
against thioredoxin reductase; TrxR-3', thioredoxin
reductase 3'-replacement parasite.
|
|
 |
DISCUSSION |
The thioredoxin redox system is involved in a variety of important
cellular functions, which include the maintenance of the intracellular
reducing environment, the reduction of ribonucleotides and hence DNA
synthesis, and the regulation of transcription of certain genes by
interaction with transcription factors (15-19, 49). Furthermore, it
has been shown that TrxR/Trx are components of an efficient antioxidant
system in the cell (7, 12, 13). Despite these important roles, a
functional thioredoxin redox system is dispensable in bacteria and
yeast, and it was shown that there appears to be a high degree of
redundancy for almost all proteins of the thioredoxin redox cascade, as
long as there is a second system present in the cell that can
compensate for the loss of function of the Trx system (50). Knockout
studies of the Trx system in mice and D. melanogaster impair embryonic and larval development, and it
is presumed that the reduced capacity to adequately protect cells from
cytotoxic damage is the cause for the deleterious effect (51, 52).
Based on the finding that trxR null mutants were not viable,
we postulate that in P. falciparum blood stage forms the Trx system is not dispensable and cannot be replaced by, for instance, the
glutathione redox system despite their overlapping functions. Thus the
level of redundancy between both systems appears to be not as profound
as in yeast or bacterial systems and is more similar to the situation
in higher eukaryotes.
In order to prove that the trxR locus was indeed targeted, a
control experiment was performed that leads to the replacement of the
3' region of the trxR gene upon homologous recombination of
the construct pHH1TrxR-3'R. Parasites obtained after integration of the
control construct did not show any phenotypic alterations when compared
with the wild type strain. To rescue trxR null mutants, a
co-transfection of both pHH1-TrxR-ko and pHC1-TrxR was conducted. This
was mainly done because currently there are only limited numbers of
selectable markers available for the transfection of P. falciparum. Both constructs possess DHFR as selectable markers and
confer resistance to pyrimethamine; however, the human DHFR also
confers resistance to WR 99120 (31, 32, 36, 37). Therefore, parasite
clones were selected by using both drugs, and it was shown that indeed
both plasmids reside in the trxR gene locus of clones 7D and
11E. These results indicate that the lethal effect of the
trxR knockout can be compensated by overexpressing the gene
from a recombinant source.
The genotype of the co-transfected parasites was investigated in more
detail, and it was shown that the co-transfected plasmids form
complexes via homologous recombination prior to integration into the
trxR gene locus. The plasmid rescue as well as the
subsequent Southern blot, PFGE, and FIGE experiments strongly support
this hypothesis. It has been shown previously that recombination
events lead to the formation of concatameric complexes (unstable
replicating forms) between episomal copies of the constructs
transfected into P. falciparum (47, 48). It is presumed that
transfected plasmids need to form unstable replicating forms to be
maintained within the parasite, because they are essential for correct
segregation to daughter cells during the erythrocytic cycle of the
parasites (48). PFGE shows that both constructs were present on
chromosome 9, and FIGE shows that at least three copies of the
constructs were integrated into the trxR gene locus. The
hypothesis that the concomitant transfection of the overexpression
construct led to a compensation of trxR loss of function is
shown by the normal growth of clones 7D and 11E.
Northern blot analyses confirmed that trxR was expressed at
high levels, which is also reflected by the elevated protein levels found in those clones. The amplified expression on mRNA and protein level in comparison with wild type or control parasites is mainly attributable to the calmodulin promoter that drives the expression of
the recombinantly introduced trxR gene from pHC1 (32,
46).
In conclusion the results presented here show that a co-transfection of
knockout and overexpression constructs is a suitable method to
complement a lethal disruption of an essential gene in P. falciparum. By using this method our study validates P. falciparum thioredoxin reductase as a potential target for the development of new antimalarials and highlights the importance of
functional antioxidant and redox systems for the survival of the
erythrocytic stages of P. falciparum.
 |
FOOTNOTES |
*
This work was supported in part by the Deutsche
Forschungsgemeinschaft Grants DFG MU837/1-1 and DFG WA395/14-4 and the
Wellcome Trust.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Performed this work as part of a doctoral study at the Faculty of
Biology, University of Hamburg, Germany.
Recipient of an Emmy-Nöther-Fellowship.

Wellcome Trust Senior Fellow. To whom correspondence should be
addressed: University of Dundee, School of Life Sciences, Division of
Biological Chemistry and Molecular Microbiology, MSI/WTB Complex, Dundee DD1 5EH, Scotland, UK. Tel.: 44-1382-345760; Fax: 44-1382- 345764; E-mail: s.muller@dundee.ac.uk.
Published, JBC Papers in Press, May 9, 2002, DOI 10.1074/jbc.M203539200
 |
ABBREVIATIONS |
The abbreviations used are:
ROS, reactive oxygen
species;
DHFR, dihydrofolate reductase;
DHFR-TS, dihydrofolate
reductase-thymidylate synthase;
FIGE, field inverse gel
electrophoresis;
PbDT, Plasmodium
berghei dihydrofolate reductase-thymidylate synthase;
PFGE, Pulse field gel electrophoresis;
Trx, thioredoxin;
TrxR, thioredoxin
reductase;
UTR, untranslated region.
 |
REFERENCES |
| 1.
|
Sies, H.
(1986)
Angew. Chem.
98,
1061-1075
|
| 2.
|
Sies, H.
(1989)
Naturwissenschaften
76,
57-64[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Ginsburg, H.,
and Atamna, H.
(1994)
Parasite
1,
5-13[Medline]
[Order article via Infotrieve]
|
| 4.
|
Hunt, N. H.,
and Stocker, R.
(1990)
Blood Cells
16,
499-526[Medline]
[Order article via Infotrieve]
|
| 5.
|
Vennerstrom, J. L.,
and Eaton, J. W.
(1988)
J. Med. Chem.
31,
1269-1277[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Meierjohann, S.,
Walter, R. D.,
and Müller, S.
(2002)
Biochem. J.
363,
833-838[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Krnajski, Z.,
Gilberger, T. W.,
Walter, R. D.,
and Müller, S.
(2001)
Mol. Biochem. Parasitol.
112,
219-228[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Lüersen, K.,
Walter, R. D.,
and Müller, S.
(2000)
Biochem. J.
346,
545-552
|
| 9.
|
Kanzok, S. M.,
Schirmer, R. H.,
Turbachova, I.,
Iozef, R.,
and Becker, K.
(2000)
J. Biol. Chem.
275,
40180-40186[Abstract/Free Full Text]
|
| 10.
|
Gilberger, T. W.,
Walter, R. D.,
and Müller, S.
(1997)
J. Biol. Chem.
272,
29584-29589[Abstract/Free Full Text]
|
| 11.
|
Färber, P. M.,
Becker, K.,
Müller, S.,
Schirmer, R. H.,
and Franklin, R. M.
(1996)
Eur. J. Biochem.
239,
655-661[Medline]
[Order article via Infotrieve]
|
| 12.
|
Rahlfs, S.,
and Becker, K.
(2001)
Eur. J. Biochem.
268,
1404-1409[Medline]
[Order article via Infotrieve]
|
| 13.
|
Kawazu, S.,
Komaki, K.,
Tsuji, N.,
Kawai, S.,
Ikenoue, N.,
Hatabu, T.,
Ishikawa, H.,
Matsumoto, Y.,
Himeno, K.,
and Kano, S.
(2001)
Mol. Biochem. Parasitol.
116,
73-79[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Krnajski, Z.,
Walter, R. D.,
and Müller, S.
(2001)
Mol. Biochem. Parasitol.
113,
303-308[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Hirota, K.,
Murata, M.,
Sachi, Y.,
Nakamura, H.,
Takeuchi, J.,
Mori, K.,
and Yodoi, J.
(1999)
J. Biol. Chem.
274,
27891-27897[Abstract/Free Full Text]
|
| 16.
|
Demple, B.
(1998)
Science
279,
1655-1656[Free Full Text]
|
| 17.
|
Zheng, M.,
Aslund, F.,
and Storz, G.
(1998)
Science
279,
1718-1721[Abstract/Free Full Text]
|
| 18.
|
Jin, D. Y.,
Chae, H. Z.,
Rhee, S. G.,
and Jeang, K. T.
(1997)
J. Biol. Chem.
272,
30952-30961[Abstract/Free Full Text]
|
| 19.
|
Holmgren, A.
(1977)
Biochem. Soc. Trans.
5,
611-612[Medline]
[Order article via Infotrieve]
|
| 20.
|
Kanzok, S. M.,
Fechner, A.,
Bauer, H.,
Ulschmid, J. K.,
Muller, H. M.,
Botella-Munoz, J.,
Schneuwly, S.,
Schirmer, R.,
and Becker, K.
(2001)
Science
291,
643-646[Abstract/Free Full Text]
|
| 21.
|
Williams, C. H.,
Arscott, L. D.,
Müller, S.,
Lennon, B. W.,
Ludwig, M. L.,
Wang, P. F.,
Veine, D. M.,
Becker, K.,
and Schirmer, R. H.
(2000)
Eur. J. Biochem.
267,
6110-6117[Medline]
[Order article via Infotrieve]
|
| 22.
|
Becker, K.,
Gromer, S.,
Schirmer, R. H.,
and Müller, S.
(2000)
Eur. J. Biochem.
267,
6118-6125[Medline]
[Order article via Infotrieve]
|
| 23.
|
Buettner, C.,
Harney, J. W.,
and Berry, M. J.
(1999)
J. Biol. Chem.
274,
21598-21602[Abstract/Free Full Text]
|
| 24.
|
Kreimer, S.,
Sohling, B.,
and Andreesen, J. R.
(1997)
Arch. Microbiol.
168,
328-337[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Müller, S.,
Gilberger, T. W.,
Färber, P. M.,
Becker, K.,
Schirmer, R. H.,
and Walter, R. D.
(1996)
Mol. Biochem. Parasitol.
80,
215-219[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Jacquot, J. P.,
Rivera-Madrid, R.,
Marinho, P.,
Kollarova, M., Le,
Marechal, P.,
Miginiac-Maslow, M.,
and Meyer, Y.
(1994)
J. Mol. Biol.
235,
1357-1363[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Cohen, G.,
Yanko, M.,
Mislovati, M.,
Argaman, A.,
Schreiber, R., Av-,
Gay, Y.,
and Aharonowitz, Y.
(1993)
J. Bacteriol.
175,
5159-5167[Abstract/Free Full Text]
|
| 28.
|
Oblong, J. E.,
Gasdaska, P. Y.,
Sherrill, K.,
and Powis, G.
(1993)
Biochemistry
32,
7271-7277[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Wang, P. F.,
Arscott, L. D.,
Gilberger, T. W.,
Müller, S.,
and Williams, C. H., Jr.
(1999)
Biochemistry
38,
3187-3196[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Gilberger, T. W.,
Bergmann, B.,
Walter, R. D.,
and Müller, S.
(1998)
FEBS Lett.
425,
407-410[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Reed, M. B.,
Saliba, K. J.,
Caruana, S. R.,
Kirk, K.,
and Cowman, A. F.
(2000)
Nature
403,
906-909[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Crabb, B. S.,
Triglia, T.,
Waterkeyn, J. G.,
and Cowman, A. F.
(1997)
Mol. Biochem. Parasitol.
90,
131-144[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Trager, W.,
and Jensen, J. B.
(1976)
Science
193,
673-675[Abstract/Free Full Text]
|
| 34.
|
Lambros, C.,
and Vanderberg, J. P.
(1979)
J. Parasitol.
65,
418-420[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Wu, Y.,
Sifri, C. D.,
Lei, H. H., Su, X. Z.,
and Wellems, T. E.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
973-977[Abstract/Free Full Text]
|
| 36.
|
Wu, Y.,
Kirkman, L. A.,
and Wellems, T. E.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
1130-1134[Abstract/Free Full Text]
|
| 37.
|
Crabb, B. S.,
and Cowman, A. F.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
7289-7294[Abstract/Free Full Text]
|
| 38.
|
Kirkman, L. A., Su, X. Z.,
and Wellems, T. E.
(1996)
Exp. Parasitol.
83,
147-149[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Lüersen, K.,
Walter, R. D.,
and Müller, S.
(1999)
Mol. Biochem. Parasitol.
98,
131-142[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Kyes, S.,
Pinches, R.,
and Newbold, C.
(2000)
Mol. Biochem. Parasitol.
105,
311-315[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Chu, G.,
Vollrath, D.,
and Davis, R. W.
(1986)
Science
234,
1582-1585[Abstract/Free Full Text]
|
| 42.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 43.
|
Umlas, J.,
and Fallon, J. N.
(1971)
Am. J. Trop. Med. Hyg.
20,
527-529[Abstract/Free Full Text]
|
| 44.
|
Trenholme, K. R.,
Gardiner, D. L.,
Holt, D. C.,
Thomas, E. A.,
Cowman, A. F.,
and Kemp, D. J.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
4029-4033[Abstract/Free Full Text]
|
| 45.
|
Patankar, S.,
Munasinghe, A.,
Shoaibi, A.,
Cummings, L. M.,
and Wirth, D. F.
(2001)
Mol. Biol. Cell
12,
3114-3125[Abstract/Free Full Text]
|
| 46.
|
Triglia, T.,
Healer, J.,
Caruana, S. R.,
Hodder, A. N.,
Anders, R. F.,
Crabb, B. S.,
and Cowman, A. F.
(2000)
Mol. Microbiol.
38,
706-718[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Kadekoppala, M.,
Cheresh, P.,
Catron, D., Ji, D. D.,
Deitsch, K.,
Wellems, T. E.,
Seifert, H. S.,
and Haldar, K.
(2001)
Mol. Biochem. Parasitol.
112,
211-218[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
O'Donnell, R.,
Preiser, P. R.,
Williamson, D. H.,
Moore, P. W.,
Cowman, A. F.,
and Crabb, B. S.
(2001)
Nucleic Acids Res.
29,
716-724[Abstract/Free Full Text]
|
| 49.
|
Aslund, F.,
and Beckwith, J.
(1999)
Cell
96,
751-753[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Carmel-Harel, O.,
and Storz, G.
(2000)
Annu. Rev. Microbiol.
54,
439-461[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Missirlis, F.,
Phillips, J. P.,
and Jäckle, H.
(2001)
Curr. Biol.
11,
1272-1277[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Matsui, M.,
Oshima, M.,
Oshima, H.,
Takaku, K.,
Maruyama, T.,
Yodoi, J.,
and Taketo, M. M.
(1996)
Dev. Biol.
178,
179-185[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Thompson, J. K.,
Rubio, J. P.,
Caruana, S.,
Brockman, A.,
Wickham, M. E.,
and Cowman, A. F.
(1997)
Mol. Biochem. Parasitol.
87,
49-60[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. J. McMillan, L. D. Arscott, D. P. Ballou, K. Becker, C. H. Williams Jr., and S. Muller
Identification of Acid-Base Catalytic Residues of High-Mr Thioredoxin Reductase from Plasmodium falciparum
J. Biol. Chem.,
November 3, 2006;
281(44):
32967 - 32977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Massimine, M. T. McIntosh, L. T. Doan, C. E. Atreya, S. Gromer, W. Sirawaraporn, D. A. Elliott, K. A. Joiner, R. H. Schirmer, and K. S. Anderson
Eosin B as a Novel Antimalarial Agent for Drug-Resistant Plasmodium falciparum.
Antimicrob. Agents Chemother.,
September 1, 2006;
50(9):
3132 - 3141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Missall and J. K. Lodge
Thioredoxin Reductase Is Essential for Viability in the Fungal Pathogen Cryptococcus neoformans
Eukaryot. Cell,
February 1, 2005;
4(2):
487 - 489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Akerman and S. Muller
Peroxiredoxin-linked Detoxification of Hydroperoxides in Toxoplasma gondii
J. Biol. Chem.,
January 7, 2005;
280(1):
564 - 570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Yeh, T. Hanekamp, S. Tsoka, P. D. Karp, and R. B. Altman
Computational Analysis of Plasmodium falciparum Metabolism: Organizing Genomic Information to Facilitate Drug Discovery
Genome Res.,
May 1, 2004;
14(5):
917 - 924.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Campanale, C. Nickel, C. A. Daubenberger, D. A. Wehlan, J. J. Gorman, N. Klonis, K. Becker, and L. Tilley
Identification and Characterization of Heme-interacting Proteins in the Malaria Parasite, Plasmodium falciparum
J. Biol. Chem.,
July 18, 2003;
278(30):
27354 - 27361.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|